No Data
No Data
MediPharm Labs Brief: Selling Its Napanee Facility to Kensana Health for $5.5 Million
MediPharm Labs Corp. Brief: Announcing Departure of President and Co-Founder Keith Strachan
MediPharm Labs Corp. Brief: Net Revenue $10.3 Million in Q2 2024; Adjusted EBITDA Negative $124K
MediPharm Labs Corp. Brief: Acquiring Advanced Medical Cannabis Delivery Method Technology From Remidose Aerosols
MediPharm Labs Corp. Brief: Anticipates Further Improvement on Profitability in 2024 With Plans Being Implemented to Improve Adjusted EBITDA by a Further $1-$2 Million
MediPharm Labs Corp. Brief: Revenue Increased 67% to $9.8 Million During the Three Months Ended March 31, 2024, Versus Revenue for the Same Quarter in 2023 of $5.8 Million
No Data